John R. Falck
individual
About
John R. Falck is an American organic chemist and biochemistry professor at the University of Texas Southwestern Medical Center. He is publicly associated with the scientific discovery and development of omega-3 fatty-acid metabolite analogues that became the basis of OMEICOS Therapeutics. His public profile is that of a senior academic scientist and translational research co-founder, not a fund manager or documented angel investor.
Areas of interest
biotechmedicinal chemistryorganic chemistrycardiovascular diseaseatrial fibrillationomega-3 lipid mediatorstranslational drug discovery